针对 GDF15 针对肥胖治疗的信号:最近的进展和新出现的挑战
Jincheng Zhang1,2,3, Jingquan Sun2, Jielang Li1
1Division of Abdominal Tumor Multimodality Treatment, Department of Medical Oncology, Cancer Center and National Clinical Research Center for Geriatrics and Laboratory of Molecular Targeted Therapy in Oncology, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
该GDF15-GFRAL通路调节新陈代谢和体重. 针对这种途径提供了一个有前途的肥胖治疗策略,对肌肉质量的影响最小.
科学领域:
- 代谢研究的研究.
- 肥胖研究的研究.
- 内分泌学 在内分泌学.
背景情况:
- 肥胖是一个全球性的健康危机,需要新的治疗方法.
- 增长差异化因子15 (GDF15) - 质细胞衍生的神经营养因子家族受体α类 (GFRAL) 途径是代谢调节的组成部分.
- 在减肥期间保持骨肌肉质量至关重要.
研究的目的:
- 审查GDF15-GFRAL轴的调节,分布和代谢作用.
- 探索针对肥胖症治疗的GDF15-GFRAL途径的潜力.
- 讨论GDF15-GFRAL向肥胖疗法的最新进展和挑战.
主要方法:
- 临床前和临床研究的文献综述.
- 对GDF15-GFRAL通路机制的分析.
- 探索针对GDF15-GFRAL轴的治疗策略.
主要成果:
- GDF15-GFRAL通路显著影响食欲和体重.
- 针对这种途径显示出对肥胖治疗的前景.
- 这种方法可以在减肥期间保持骨肌肉质量.
结论:
- GDF15-GFRAL轴是能量恒温的关键调节器.
- 准GDF15-GFRAL途径是一个可行的策略来打击肥胖.
- 需要进一步的研究来克服临床应用中的挑战.
更多相关视频
13:09Segmentation and Measurement of Fat Volumes in Murine Obesity Models Using X-ray Computed Tomography
Published on: April 4, 2012
10:28Isolation, Expansion, and Adipogenic Induction of CD34+CD31+ Endothelial Cells from Human Omental and Subcutaneous Adipose Tissue
Published on: July 17, 2018
相关概念视频
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Hormonal Regulation
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Obesity
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
